Lung Cancer clinical trials
Showing 51–100 of 230 active trials. Describe your situation to see which ones you may be eligible for.
- Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
- Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
- Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
- TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
- Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
- Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
- Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.
- A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
- Using Xe MRI to Guide Radiation Therapy for Lung Cancer
- LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
- Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
- Advancing Lung Cancer Screening One Text at a Time
- TELESCOPE- TELEhealth Shared Decision-making COaching
- EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
- PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
- Prediction Augmented Screening Initiative
- The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
- Increasing Lung Cancer Screening Uptake Among Emergency Department Patients
- Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
- Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- Lung Cancer Screening in High-risk Black Individuals
- Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
- Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention
- Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System
- LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
- Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
- A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
- Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
- CPRIT: Patient Adherence to Lung Cancer Screening
- Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
- Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
- A Study of Lung Cancer Screening in People With Unexplained Weight Loss
- Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
- Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
- Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Rural Illinois Lung Cancer Screening Initiative
- Health Opportunities and Promoters of Equitable Screening for Lung Cancer
- MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
- Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
- The Rise in Robotic Atypical Segmentectomies
- Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
- Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
- Collection of Sputum and Labeling for Lung Cancer
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.